Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: Current status

Radiation Research

Volumn 176, Issue 4, 2011, Pages 508-520

  Takam, R ^a,b   Bezak, E ^a,b   Marcu, L G ^a,b,c   Yeoh, E ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF ORADEA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; HUMAN; LIGHT EXPOSURE; LINEAR ACCELERATOR; MEASUREMENT; MONTE CARLO METHOD; NEUTRON; PHOTON; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RISK ASSESSMENT; SECOND CANCER; TECHNIQUE;

ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MONTE CARLO METHOD; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NEUTRONS; PHOTONS; RADIATION MONITORING; RADIOTHERAPY DOSAGE; RISK;

EID: 80053243123     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2606.1     Document Type: Article

References (55)

1. d'Errico F, Nath R, Tana L, Curzio G, Alberts WG. In-phantom dosimetry and spectrometry of photoneutrons from an 18 MV linear accelerator. Med Phys 1998;25: 1717-24. (Pubitemid 28430894)
2. Huang WL, Li QF, Lin YZ. Calculation of photoneutrons produced in the targets of electron linear accelerators for radiography and radiotherapy applications. Nucl Instrum Methods Phys Res B 2005; 229:339-47. (Pubitemid 40304293)
3. Howell RM, Ferenci MS, Hertel NE, Fullerton GD. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 2006; 33:360-68. (Pubitemid 43183978)
4. Vanhavere F, Huyskens D, Struelens L. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. Radiat Prot Dosimetry 2004; 110:607-12. (Pubitemid 39276802)
5. Carinou E, Stamatelatos IE, Kamenopoulou V, Georgolopoulou V, Sandilos P. An MCNP-based model for the evaluation of the photoneutron dose in high energy medical electron accelerators. Phys Med 2005; 21:95-9. (Pubitemid 41608013)
6. Lin JP, Chu TC, Lin SY, Liu MT. The measurement of photoneutrons in the vicinity of a Siemens Primus linear accelerator. Appl Radiat Isot 2001; 55:315-21.
7. Facure A, Falcao RC, Silva AX, Crispim VR, Vitorelli JC. A study of neutron spectra from medical linear accelerators. Appl Radiat Isot 2005; 62:69-72. (Pubitemid 39446104)
8. d'Errico F, Luszik-Bhadra M, Nath R, Siebert BR, Wolf U. Depth dose-equivalent and effective energies of photoneutrons generated by 6-18 MV X-ray beams for radiotherapy. Health Phys 2001; 80:4-11 (Pubitemid 32009607)
9. ICRP. Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 2007; 37(2-4).
10. Cember H. Introduction to health physics. 3rd ed. New York: McGraw-Hill Professional; 2000.
11. Wang B, Xu XG. Measurements of non-target organ doses using MOSFET dosemeters for selected IMRT and 3D-CRT radiation treatment procedures. Radiat Prot Dosimetry 2008; 128:336-42. (Pubitemid 351827490)
12. Kry SF, Salehpour M, Followill DS, StovallM, Kuban DA, White RA, et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005; 62:1204-16. (Pubitemid 40884436)
13. Harrison RM, Wilkinson M, Shemilt A, Rawlings DJ, Moore M, Lecomber AR. Organ doses from prostate radiotherapy and associated concomitant exposures. Br J Radiol 2006; 79:487-96. (Pubitemid 43933446)
14. Liu JC, Kase KR, Mao XS, Nelson WR, Kleck JH, Johnson S. Calculations of photoneutrons from Varian Clinac accelerators and their transmissions in materials Radiation Dosimetry and Safety. Stanford (California): SLAC National Accelerator Laboratory; 1997. pp. 1-5.
15. Ongaro C, Zanini A, Nastasi U, Rodenas J, Ottaviano G, Manfredotti C. Analysis of photoneutron spectra produced in medical accelerators. Phys Med Biol 2000; 45:L55-61. (Pubitemid 32005270)
16. Barquero R, Mendez R, Iniguez MP, Vega HR, Voytchev M. Thermoluminescence measurements of neutron dose around a medical linac. Radiat Prot Dosimetry 2002; 101:493-6.
17. Chibani O, Ma CM. Photonuclear dose calculations for high-energy photon beams for Siemens and Varian linacs. Med Phys 2003; 30:1990-2000. (Pubitemid 37022006)
18. Waller EJ, Jamieson TJ, Cole D, Cousins T, Jammal RB. Experimental and computational determination of neutron dose equivalent around radiotherapy accelerators. Radiat Prot Dosimetry 2003; 107:225-32. (Pubitemid 38139468)
19. Zanini A, Durisi E, Fasolo F, Ongaro C, Visca L, Nastasi U, et al. Monte Carlo simulation of the photoneutron field in linac radiotherapy treatments with different collimation systems. Phys Med Biol 2004; 49:571-82. (Pubitemid 38255939)
20. Chen CC, Sheu RJ, Yeh CY, Lin UT, Jiang SH. A detailed study on the neutron contamination for a 10 MeV medical electron accelerator. Nucl Instrum Methods Phys Res A 2006; 562: 1033-7. (Pubitemid 43831314)
21. Reft CS, Runkel-Muller R, Myrainthopoulos L. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT. Med Phys 2006; 33:3734-42. (Pubitemid 44505099)
22. Brunckhorst E, Sheng X, Todorovic M, Becker J, Cremers F. Characterisation of MCP-600D and MCP-700D thermolumi-nescence detectors and their applicability for photoneutron detection. Radiat Prot Dosimetry 2008; 131:513-20.
23. Jaradat AK, Biggs PJ. Measurement of the neutron leakage from a dedicated intraoperative radiation therapy electron linear accelerator and a conventional linear accelerator. Med Phys 2008; 35:1711-7. (Pubitemid 351614785)
24. Ruben JD, Davis S, Evans C, Jones P, Gagliardi F, Haynes M, et al. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys 2008; 70:1530-6.
25. Mesbahi A. A Monte Carlo study on neutron and electron contamination of an unflattened 18-MV photon beam. Appl Radiat Isot 2009; 67:55-60.
26. Mesbahi A, Keshtkar A, Mohammadi E, Mohammadzadeh M. Effect of wedge filter and field size on photoneutron dose equivalent for an 18 MV photon beam of a medical linear accelerator. Appl Radiat Isot 2010; 68:84-9
27. ICRU Report 13. Neutron fluence, neutron spectra and kerma. Washington, DC: International Commission on Radiation Units and Measurements; 1969.
28. McKeever SWS, Moskovitch M, Townsend PD. Thermolum-inescence dosimetry materials: properties and uses. Kent, England: Nuclear Technology Publishing; 1995.
29. Itoh M, Yamada Y, Kiriyama N, Komura K, Ueno K, Sakanoue M. Neutron activation analysis of low level lithium in water samples. J Radioanalyt Nucl Chem 1993; 172:289-98. (Pubitemid 23291572)
30. Barquero R, Mendez R, Vega-Carrillo HR, Iniguez MP, Edwards TM. Neutron spectra and dosimetric features around an 18 MV linac accelerator. Health Phys 2005; 88:48-58. (Pubitemid 40165358)
31. Xu XG, Bednarz B, Paganetti H. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol 2008; 53:R193-241. (Pubitemid 352020053)
32. Kry SF, Salehpour M, Followill DS, StovallM, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005; 62:1195-203. (Pubitemid 40884435)
33. Bednarz B, Athar B, Xu XG. A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models. Med Phys 2010; 37:1987-94.
34. Zwahlen DR, Ruben JD, Jones P, Gagliardi F, Millar JL, Schneider U. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 2009; 74:539-45.
35. Boice JD, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988; 116:3-55.
36. Movsas B, Hanlon AL, Pinover W, Hancks GE. Is there an increased risk of second primaries following prostate irradiations? Int J Radiat Oncol Biol Phys 1998; 41:251-5. (Pubitemid 28243533)
37. Levi F, Randimbison L, Te Van-Cong., Erler G, La Vecchia C. Second primary tumours after prostate carcinoma. Cancer 1999; 86:1567-70. (Pubitemid 29489792)
38. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88:398-406. (Pubitemid 30051826)
39. Pickles T, Phillips N. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000. Radiother Oncol 2002; 65:145-51. (Pubitemid 35441045)
40. Thellenberg C, Malmer B, Tavelin B, Gronberg H. Second primary cancers in men with prostate cancer: An increased risk of male breast cancer. J Urol 2003; 169:1345-8. (Pubitemid 36323781)
41. Travis LB, Fossa° SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005; 97:1354-65. (Pubitemid 41487803)
42. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007; 99:1634-43.
43. Bhojani N, Capitanio U, Suardi N, Jeldres C, Isbarn H, Shariat SF, et al. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys 2010; 76:342-8.
44. Huang J, Kestin LL, Ye H, Wallace M, Martinez AA, Vicini FA. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiother Oncol 2011; 98:81-6.
45. Kleinerman RA, Curtis RE, Boice JD Jr, Flannery JT, Fraumeni JF Jr. Second cancers following radiotherapy for cervical cancer. J Natl Cancer Inst 1982; 69:1027-33. (Pubitemid 13254891)
46. Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, et al. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010; 102:220-6.
47. Bostrom PJ, Soloway MS. Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? Eur Urol 2007; 52:973-82. (Pubitemid 47332061)
48. Rebello WF, Silva AX, Facure A. Multileaf shielding design against neutrons produced by medical linear accelerator. Radiat Prot Dosimetry 2008; 128:227-33. (Pubitemid 351827508)
49. Hall EJ, Martin SG, Amols H, Hei TK. Photoneutrons from medical linear accelerators-radiobiological measurements and risk estimates. Int J Radiat Oncol Biol Phys 1995; 33:225-30.
50. Howell RM, Scarboro SB, Taddei PJ, Krishnan S, Kry SF, Newhauser WD. Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy. Phys Med Biol 2010; 55:7009-7023.
51. Forget P, Dresse MF, Schmitz V, Hoyoux C. Secondary cancers in childhood. Rev Med Liege 2006; 61:76-80. (Pubitemid 43342803)
52. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102:1083-95.
53. Ragusa R, Russo S, Villari L, Schilirò G. Hodgkin's disease as a second malignant neoplasm in childhood: report of a case and review of the literature. Pediatr Hematol Oncol 2001; 18:407-14. (Pubitemid 32822628)
54. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2006; 24:476-83. (Pubitemid 46630467)
55. Gow KW, Lensing S, Hill DA, Krasin MJ, McCarville MB, Rai SN, et al. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature. J Pediatr Surg 2003; 38:1574-80. (Pubitemid 37413852)